Utah Medical Products(DE:UTM)
€64.00+0.00 (+6.67%)
DE:UTM
Utah Medical Products financials statements
€64.00
At close:+0.00 (+6.67%)
Utah Medical Products (UTM) Financial Statements
0 Followers
Utah Medical Products Financial Overview
Utah Medical Products's market cap is currently $187.07M. The company's EPS TTM is $3.34; its P/E ratio is 21.85; and it has a dividend yield of 1.62%. Utah Medical Products has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 38.52M | $ 40.90M | $ 50.22M | $ 52.28M | $ 49.05M |
| Gross Profit | $ 22.00M | $ 24.14M | $ 30.04M | $ 32.20M | $ 30.92M |
| Operating Income | $ 11.40M | $ 13.59M | $ 16.78M | $ 19.79M | $ 18.88M |
| EBITDA | $ 17.06M | $ 19.65M | $ 24.75M | $ 27.74M | $ 26.34M |
| Net Income | $ 11.29M | $ 13.87M | $ 16.64M | $ 16.47M | $ 14.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 85.76M | $ 82.98M | $ 92.87M | $ 75.05M | $ 60.97M |
| Total Assets | $ 122.54M | $ 122.54M | $ 135.46M | $ 123.87M | $ 115.64M |
| Total Debt | $ 225.00K | $ 338.00K | $ 295.00K | $ 341.00K | $ 396.00K |
| Net Debt | $ -85.53M | $ -82.69M | $ -92.57M | $ -74.71M | $ -60.58M |
| Total Liabilities | $ 3.27M | $ 5.11M | $ 7.14M | $ 9.62M | $ 8.50M |
| Stockholders' Equity | $ 119.27M | $ 117.43M | $ 128.31M | $ 114.25M | $ 107.14M |
| Cash Flow | |||||
| Free Cash Flow | $ 14.32M | $ 14.60M | $ 21.64M | $ 20.33M | $ 20.65M |
| Operating Cash Flow | $ 14.69M | $ 14.83M | $ 22.28M | $ 21.15M | $ 21.20M |
| Investing Cash Flow | $ -371.00K | $ -208.00K | $ -639.00K | $ -818.00K | $ -552.00K |
| Financing Cash Flow | $ -12.34M | $ -23.84M | $ -4.17M | $ -5.48M | $ -10.90M |
Currency in USD
